1,000
Views
0
CrossRef citations to date
0
Altmetric
HPV – Research Article

Feasibility and sustainability of a nurse-led intervention to integrate HPV vaccination into medical processing for active-duty Soldiers

, , , , , & show all
Article: 2153536 | Received 11 Sep 2022, Accepted 25 Nov 2022, Published online: 20 Dec 2022

References

  • Centers for Disease Control and Prevention. Genital HPV infection – fact sheet 2022. [accessed 2022 Jan 18]. https://www.cdc.gov/std/hpv/stdfact-hpv.htm.
  • U.S. Centers for Disease Control and Prevention. Cancers associated with human papillomavirus United States—2013–2017. Atlanta, GA; 2020.
  • Buechel JJ. Vaccination for human papillomavirus immunization practices in the U.S. military. Clin J Oncol Nurs. 2018;22(1):22. doi:10.1188/18.CJON.104-107.
  • Seay J, Matsuno R, Jennifer Buechel C, Tannenbaum K, Natalie Wells C. HPV-related cancers: a growing threat to U.S. military health and readiness. Mil Med. 2021;187(5–6):149–7. doi:10.1093/milmed/usab443.
  • U.S. Centers for Disease Control and Prevention. HPV vaccine; 2021 [accessed 2022 Jan 18]. https://www.cdc.gov/hpv/parents/vaccine-for-hpv.html.
  • Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019;68(32):698–702. doi:10.15585/MMWR.MM6832A3.
  • Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA Jr, Unger ER. Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63(RR-05):1–30.
  • Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383(14):1340–48. doi:10.1056/nejmoa1917338.
  • Shen-Gunther J, Shank JJ, Ta V. Gardasil™ HPV vaccination: surveillance of vaccine usage and adherence in a military population. Gynecol Oncol. 2011;123(2):272–77. doi:10.1016/J.YGYNO.2011.07.094.
  • Clark LL, Stahlman S, Taubman SB. Human papillomavirus vaccine initiation coverage and completion rates among U.S. active component service members 2007–2017. MSMR. 2018;25:9–14.
  • Sitler CA, Weir LF, Keyser EA, Casablanca Y, Hope E. Mandatory HPV vaccination; opportunity to save lives improve readiness and cut costs. Mil Med. 2021;186(11–12):305–08. doi:10.1093/MILMED/USAB232.
  • Army Regulation 40-562: immunizations and chemoprophylaxis for the prevention of infectious diseases 2013. [accessed 2022 Jan 18]. https://www.health.mil/Reference-Center/POlicies/2013/10/07/Immunizations-and-Chemoprophylaxis-for-the-Prevention-of-Infectious-Diseases.
  • Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139(1):139. doi:10.1542/peds.2016-1764.
  • Malo TL, Hall ME, Brewer NT, Lathren CR, Gilkey MB. Why is announcement training more effective than conversation training for introducing HPV vaccination? A theory-based investigation. Implement Sci. 2018;13(1):13. doi:10.1186/s13012-018-0743-8.
  • National Institutes of Health: National Cancer Institute. DOSE HPV: development of systems and education for HPV vaccination | Evidence-Based Cancer Control Programs (EBCCP). 2020 [accessed 2022 Jan 18]. https://ebccp.cancercontrol.cancer.gov/programDetails.do?programId=25930477.
  • Malo TL, Gilkey MB, Hall ME, Shah PD, Brewer NT. Messages to motivate human papillomavirus vaccination: national studies of parents and physicians. Cancer Epidemiol Biomarkers Prev. 2016;25(10):1383–91. doi:10.1158/1055-9965.EPI-16-0224.
  • Shah PD, Calo WA, Gilkey MB, Boynton MH, Dailey SA, Todd KG, Robichaud MO, Margolis MA, Brewer NT. Questions and concerns about HPV vaccine: a communication experiment. Pediatrics. 2019;212:143. doi:10.1542/PEDS.2018-1872/-/DCSUPPLEMENTAL.
  • Gilkey MB, Moss JL, Coyne-Beasley T, Hall ME, Shah PD, Brewer NT. Physician communication about adolescent vaccination: how is human papillomavirus vaccine different? Prev Med (Baltim). 2015;77:181–85. doi:10.1016/j.ypmed.2015.05.024.
  • Kornides ML, McRee AL, Gilkey MB. Parents who decline HPV vaccination: who later accepts and why? Acad Pediatr. 2018;18:S37–43. doi:10.1016/J.ACAP.2017.06.008.
  • Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. 2016;34:1187–92. doi:10.1016/j.vaccine.2016.01.023.
  • Gargano LM, Herbert NL, Painter JE, Sales JM, Morfaw C, Rask K, Murray D, DiClemente RJ, Hughes JM. Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines. Hum Vaccin Immunother. 2013;9:2627–33. doi:10.4161/hv.25823.
  • Wedel S, Navarrete R, Burkard JF, Clark MJ. Improving human papillomavirus vaccinations in military women. Mil Med. 2016;181:1224–27. doi:10.7205/MILMED-D-15-00477.
  • Dempsey AF, Pyrznawoski J, Lockhart S, Barnard J, Campagna EJ, Garrett K, Fisher A, Dickinson LM, O’Leary ST. Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination a cluster randomized clinical trial. JAMA Pediatr. 2018;172(5):e180016. doi:10.1001/jamapediatrics.2018.0016.
  • Grabert BK, Heisler-MacKinnon J, Liu A, Margolis MA, Cox ED, Gilkey MB. Prioritizing and implementing HPV vaccination quality improvement programs in healthcare systems: the perspective of quality improvement leaders. Hum Vaccin Immunother. 2021;17:3577–86. doi:10.1080/21645515.2021.1913965.